Saranas

Saranas, Inc. operates in the medical device industry, specializing in innovative bleed detection systems. The company's flagship product, the Early Bird, is the first and only FDA-approved system designed for peri and post-procedural monitoring of endovascular procedures. This system provides clinicians with accurate and actionable information to detect internal bleeds early, thereby mitigating the detrimental consequences associated with bleeding complications. Saranas primarily serves healthcare providers, including hospitals and clinics, that perform large bore endovascular procedures. The company generates revenue through the sale of its Early Bird system and related services. By addressing a critical need in the medical field, Saranas aims to improve patient outcomes and reduce healthcare costs associated with bleed complications.

Keywords: bleed detection, FDA-approved, endovascular procedures, healthcare providers, medical device, patient outcomes, cost reduction, peri-procedural monitoring, post-procedural monitoring, innovative technology.